Home/Filings/4/0001415889-25-003171
4//SEC Filing

Choi Han Wook 4

Accession 0001415889-25-003171

CIK 0001817229other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 9:19 PM ET

Size

7.5 KB

Accession

0001415889-25-003171

Insider Transaction Report

Form 4
Period: 2025-02-03
Choi Han Wook
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-02-03+52,50052,500 total
  • Award

    Employee Stock Option (right to buy)

    2025-02-03+315,000315,000 total
    Exercise: $1.34Exp: 2035-02-02Common Stock (315,000 underlying)
Footnotes (2)
  • [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2025, subject to the Reporting Person's continued service as of each such date.
  • [F2]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2025, in each case subject to the Reporting Person's continued service as of each such date.

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother

Related Parties

1
  • filerCIK 0002038629

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 9:19 PM ET
Size
7.5 KB